TechWired1h ago
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.
Read full articleSource: Wired · Opens in new tab